• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Transgenomic Inc

+ Add to Watchlist

TBIO:US

3.8500 USD 0.0800 2.04%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Transgenomic Inc (TBIO)

Open: 3.8700 Day's Range: 3.6600 - 3.9680 Volume: 66,176
Previous Close: 3.9300 52wk Range: 3.1000 - 7.4400 1-Yr Rtn: -8.33%

Stock Chart for TBIO

No chart data available.
  • TBIO:US 3.8500
  • 1D
  • 1M
  • 1Y
3.9300
Interactive TBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TBIO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2800
Est. EPS (USD) (12/2014) -1.9600
Est. PEG Ratio -
Market Cap (M USD) 28.31
Shares Outstanding (M) 7.35
30 Day Average Volume 24,960
Price/Book (mrq) 2.7352
Price/Sale (ttm) 2.0098
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TBIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TBIO

Transgenomic, Inc. provides research tools to the life sciences industry. These tools enable researchers to discover and understand variation in the human genetic code, or genome, in order to accelerate and improve drug development and diagnostics.

Paul KinnonPresident/CEOMark P ColonneseExec VP/CFO
More Company Profile & Key Executives for TBIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil